Susquehanna International Group’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $1.54M | Buy |
|
|||||
|
2025
Q1 | $1.31M | Sell |
|
|||||
|
2024
Q4 | $2.37M | Buy |
|
|||||
|
2024
Q3 | $471K | Sell |
|
|||||
|
2024
Q2 | $2.08M | Buy |
|
|||||
|
2024
Q1 | $1.69M | Sell |
|
|||||
|
2023
Q4 | $9.28M | Buy |
|
|||||
|
2023
Q3 | $4.72M | Sell |
|
|||||
|
2023
Q2 | $7.79M | Sell |
|
|||||
|
2023
Q1 | $11.6M | Buy |
|
|||||
|
2022
Q4 | $2.94M | Sell |
|
|||||
|
2022
Q3 | $5.84M | Sell |
|
|||||
|
2022
Q2 | $17.3M | Sell |
|
|||||
|
2022
Q1 | $23.8M | Sell |
|
|||||
|
2021
Q4 | $77.6M | Sell |
|
|||||
|
2021
Q3 | $84.6M | Buy |
|
|||||
|
2021
Q2 | $31.3M | Buy |
|
|||||
|
2021
Q1 | $17.6M | Sell |
|
|||||
|
2020
Q4 | $28.9M | Buy |
|
|||||
|
2020
Q3 | $20.8M | Buy |
|
|||||
|
2020
Q2 | $17.8M | Sell |
|
|||||
|
2020
Q1 | $15.9M | Buy |
|
|||||
|
2019
Q4 | $17.5M | Buy |
|
|||||
|
2019
Q3 | $3.43M | Buy |
|
|||||
|
2019
Q2 | $3.24M | Sell |
|
|||||
|
2019
Q1 | $3.7M | Buy |
|
|||||
|
2018
Q4 | $1.85M | Buy |
|
|||||
|
2018
Q3 | $862K | Sell |
|
|||||
|
2018
Q2 | $1.19M | Buy |
|
|||||
|
2018
Q1 | $493K | Sell |
|
|||||
|
2017
Q4 | $636K | Sell |
|
|||||
|
2017
Q3 | $1.93M | Buy |
|
|||||
|
2017
Q2 | $1.57M | Buy |
|
|||||
|
2017
Q1 | $1.35M | Sell |
|
|||||
|
2016
Q4 | $1.88M | Buy |
|